NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
42799-935-01 | 42799-935 | HUMAN PRESCRIPTION DRUG | Doxepin Hydrochloride | Doxepin Hydrochloride | CAPSULE | ORAL | 20220502 | N/A | ANDA | ANDA213796 | Edenbridge Pharmaceuticals LLC. | DOXEPIN HYDROCHLORIDE | 150 mg/1 | 100 CAPSULE in 1 BOTTLE (42799-935-01) |
42799-935-02 | 42799-935 | HUMAN PRESCRIPTION DRUG | Doxepin Hydrochloride | Doxepin Hydrochloride | CAPSULE | ORAL | 20220502 | N/A | ANDA | ANDA213796 | Edenbridge Pharmaceuticals LLC. | DOXEPIN HYDROCHLORIDE | 150 mg/1 | 500 CAPSULE in 1 BOTTLE (42799-935-02) |
42799-935-50 | 42799-935 | HUMAN PRESCRIPTION DRUG | Doxepin Hydrochloride | Doxepin Hydrochloride | CAPSULE | ORAL | 20220502 | N/A | ANDA | ANDA213796 | Edenbridge Pharmaceuticals LLC. | DOXEPIN HYDROCHLORIDE | 150 mg/1 | 50 CAPSULE in 1 BOTTLE (42799-935-50) |